Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Lucid Diagnostics Inc. on June 18, 2025. The company is an emerging growth company incorporated in Delaware, with its principal executive offices in New York, New York. Its common stock trades on The Nasdaq Stock Market LLC under the symbol "LUCD."
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics.
Material Changes and Voting Results
Stockholders representing approximately 70.9% of the shares outstanding were present at the meeting. The following matters were approved:
- Director Elections: Stanley N. Lapidus and Jacque J. Sokolov, M.D. were re-elected as Class A directors. Each nominee received over 63.7 million votes "For," with approximately 6.7 million votes withheld.
- Stock Issuance Proposal: Stockholders approved the issuance of common stock under the Senior Secured Convertible Notes (2024 Convertible Notes) issued in November 2024, satisfying Nasdaq Listing Rule 5635. The proposal received 69,594,336 votes "For" versus 620,749 "Against."
- Auditor Ratification: The appointment of CBIZ CPAs P.C. as the independent registered public accounting firm for the year ending December 31, 2025, was ratified with 90,003,483 votes "For."
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, or specific risk factors beyond the standard disclosures regarding the 2024 Convertible Notes. The text references a Definitive Proxy Statement filed on April 30, 2025, for a fuller description of the convertible notes offering.
Investor Verification Checklist
- Verify the terms and conversion mechanics of the 2024 Convertible Notes referenced in the November 29, 2024, Form 8-K.
- Review the Definitive Proxy Statement (Schedule 14A) filed on April 30, 2025, for detailed information on the stock issuance proposal.
- Confirm the current board composition and term expiration dates for Class B and Class C directors.
- Check subsequent filings for the company's next quarterly or annual financial results, as none are included in this report.